Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Summary

This phase II trial is studying how well ispinesib works in treating patients with metastatic or unresectable kidney cancer. Ispinesib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2006-05

Primary completion

2007-02

Completion

—

Drugs

Indications